Grundinformationen
- CAS
2756-87-8- Standard-SMILES
COC(=O)/C=C\C(=O)O- InChIKey
NKHAVTQWNUWKEO-IHWYPQMZSA-N- Summenformel
- C5H6O4
- Durchschnittliche Molmasse
- 130,1 g/mol
- Monoisotopische Masse
- 130,02660867
Namen und Bezeichner
- Bevorzugter Name
- Monomethyl maleate
- IUPAC
- (Z)-4-methoxy-4-oxobut-2-enoic acid
- Lokaler Name
- Methylhydrogenfumarat
- Englischer Name
- Monomethyl fumarate
- Summenformel
- C5H6O4
- Molmasse
- 130.1
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
2756-87-8、3052-50-4、44836-34-2- PubChem CID
- 5354456
- DTXSID
DTXSID1029251- ChEMBL
CHEMBL3181865- UNII
- U3UT1G2B9N
- EC Number
- 221-271-3
- Nikkaji
- J45.636E
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 0,4
- Polarare Oberfläche (TPSA)
- 63,6 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 9
- Formalladung
- 0
- Komplexität
- 147
Experimentelle und physikochemische Eigenschaften
Physikochemische Eigenschaften
- Schmelzpunkt
- 144 · 144-145 °C (lit.)
- Siedepunkt
- 250 · 250.0±23.0 °C(Predicted)
- Dichte
- 1.37 g/cm3 · 1.37 g/cm3
- storage temp.
- 2 · 2-8°C
- Löslichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- pka
- 3.4 · 3.40±0.10(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Off-White
- InChI
- InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+
- InChIKey
- NKHAVTQWNUWKEO-NSCUHMNNSA-N
- SMILES
- C(OC)(=O)/C=C/C(O)=O
- CAS Datenbank
- 2756 · 2756-87-8(CAS DataBase Reference)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
This chemical does not meet GHS hazard criteria for 19.1% (9 of 47) of reports.
Warning
H315 (76.6%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (78.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement)
Aggregated GHS information provided per 47 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 9 of 47 reports by companies.;There are 3 notifications provided by 38 of 47 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Regulatory Information
Chemical: 2-Butenedioic acid, monomethyl ester
Status: Active Update: 08-01-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/32042
Regulatorische Informationen
Regulatory Information
Chemical: 2-Butenedioic acid, monomethyl ester
Status: Active Update: 08-01-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/32042
Sicherheitsdaten
- wgk
- 3
- hs_code
- 29171900
- risk_code
- 41
- hazard_code
- Xi
- safety_code
- 26-39
- Speicherklasse
- 11 - Combustible Solids
- Hazard Classifications
- Eye Irrit. 2
Chemie und Industrie
Pharmakologische Informationen
Verwendung und Herstellung
Anwendungen
BeschreibungMonomethyl fumarate (MMF), a bioactive metabolite of fumaric acid ester, is an immunotherapy for psoriasis that causes decreased production of Th1 cytokines and lymphocytopenia. Monomethyl fumarate was shown to decrease DC response to LPS and decreased IL-12p70 and IL-10 production.
VerwendenMonomethyl fumarate is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease.Fumaric Acid Monomethyl Ester is one of the most bioactive anti-psoriatic fumaric acid ester metabolite. Fumaric Acid Monomethyl Ester is potent nicotinic acid receptor agonist. Fumaric Acid Monomethy l Ester has also been shown to selectively stimulate of T helper 2 cytokine response.
Darstellung
synthetischeMonomethyl fumarate was synthesized by maleic anhydride and methanol. monomethyl fumarate could inhibit the growth of mold, and the storage time of feed could be prolonged.
Anbieter100 Anbieter
Ergänzende Hinweise
DefinitionChEBI: Monomethyl fumarate is a dicarboxylic acid monoester resulting from the formal condensation of one of the carboxy groups of fumaric acid with methanol. Is is a metabolite of dimethyl fumarate and used for the the treatment of patients with relapsing multiple sclerosis (MS). It also induces the NFE2L2 (Nrf2) transcription factor by binding to KEAP1. It has a role as an immunomodulator, an antioxidant and a drug metabolite. It is an enoate ester, a methyl ester and a dicarboxylic acid monoester. It derives from a fumaric acid.
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…